A collaboration to develop biomarker technology was announced by Bristol-Myers Squibb Co. and Nordic Bioscience last week. Read More »

Incyte Corporation recently announced that it joined with the National Organization for Rare Disorders (NORD), the European Organization for Rare Disease (EURODIS) and more in recognizing Rare Disease Day 2017. Read More »

Biologics Inc. has been selected by Lexicon Pharmaceuticals to provide limited distribution of the drug Xermelo. Read More »

Pfizer Inc. and nonprofit Population Services International recently announced a $1 million collaboration that will make it easier for people with hypertension in Myanmar and Vietnam to access medicine and treatment. Read More »

McKesson Corp. and Change Healthcare Holdings Inc. have completed their agreement to build a new health care information technology company titled Change Healthcare. Read More »

Bedside delivery of medications is a practice that is helping patients live more healthily following discharge from hospitals. Read More »

Allergan PLC and Ironwood Pharmaceuticals Inc. merged forces with the American Gastroenterological Association to raise awareness about bowel health during Irritable Bowel Syndrome Awareness Month. Read More »

Endo International announced April 12 a $300 million aggregate principal amount of 5.875% senior secured notes which will be due in 2024 at the price of $1000 for each $1000 principal amount, as related to their prior announcement of private offering. Read More »

An analysis commissioned by Washington, D.C.’s Pharmaceutical Care Management Association (PCMA) recently confirmed that no correlation exists between prices and rebates contrary to claims that drug costs are proportional to consumer rebates and discounts. Read More »

Imprimis Pharmaceuticals Inc. this month gained the rights to Klarity, a new remedy for dry eye disease (DED). Read More »

A majority of the biggest patient advocacy groups in the country received drug industry funding last year, with many receiving as much as $1 million or more, a study has found. Read More »

A recent Walgreens study points to a connection between pharmacy communication and patient adherence. Read More »

CVS Health's Advanced Care Scripts has earned accreditation in Specialty Pharmacy from URAC, the leader in health care accreditation, certification and overall measurement. Read More »

Biogen has entered into a licensing agreement for BMS-986168 with Bristol-Myers Squibb to initiate Phase II studies for the antibody treatment for Alzheimer’s disease and progressive supranuclear palsy. Read More »

Shire plc recently delivered data at the American Academy of Allergy, Asthma & Immunology annual meeting on its Cuvitru drug, which treats patients with primary immunodeficiency. Read More »

Sanofi and Regeneron Pharmaceuticals recently presented Phase 3 Chronos study results at the late-breaking oral abstract session of the Annual Meeting of the American Academy of Dermatology. Read More »

Biologics Inc., which is owned by McKesson Specialty Health, has been chosen as the exclusive specialty pharmacy provider for BAVENCIO (avelumab). Read More »

Daiichi Sankyo Inc.has sold its pharmaceutical packaging plant in Bethlehem, Pennsylvania to Sharp Packaging Services, a division of UDG Healthcare. Read More »

Walgreens and Prime Therapeutics LLC merge to offer specialty pharmacy and mail services Read More »

Daiichi Sankyo Inc. recently announced the enrollment of the first person for its Eliminate-AF study. Read More »